Navigation Links
BioSoteria eLearning Executive Michelle Flewell Selected for Accreditation Council
Date:3/3/2010

BioSoteria announced today that Michelle Flewell, the company’s Vice President of eLearning and Informatics, was appointed by the Institute for Credentialing Excellence (ICE) to serve on the Certificate Accreditation Program Advisory Council. Flewell will be attending the first meeting of the Council, which is charged with developing policies and procedures for ICE accreditation of assessment-based certificate programs, on March 4, 2010, in Washington, DC.

(PRWEB) March 3, 2010 -- BioSoteria, Inc., a drug safety services and education firm, announced today that Michelle Nolin Flewell, CPLP, the company’s Vice President of eLearning and Informatics, was appointed by the Institute for Credentialing Excellence (ICE) to serve on the Certificate Accreditation Program Advisory Council. The Council was recently formed to develop policies and procedures for ICE accreditation of assessment-based certificate programs.

An assessment-based certificate program (ABCP) is a non-degree-granting instructional training program that evaluates the participant’s accomplishment of intended learning outcomes and awards a certificate only to those who meet the proficiency standard of the assessment. It differs from a certificate of attendance, which indicates only that the participant was present at the training program, and a professional certification, which is a time-limited recognition that an individual has met standardized requirements in skills, knowledge or competencies.

ICE, formerly known as the National Organization for Competency Assurance (NOCA), published the first standard for certificate programs in July 2009. ICE 1100 – Standards for Assessment-Based Certificate Programs – specifies essential requirements for certificate programs and provides guidance to program providers, consumers (both participants and employers) and others on what defines a high-quality program. The ICE standard has been accepted as an American National Standard by the American National Standards Institute (ANSI).

“There is a lot of interest and confusion in the industry related to certificate programs, including those offered in drug safety and pharmacovigilance,” said Michelle Flewell, who leads the development of BioSoteria’s eLadder™ Safety curriculum. “I am pleased to serve on a council that will help training providers develop assessment-based programs that follow internationally recognized standards for educational quality, and to clarify to training participants and employers what an accredited certificate represents.”

Flewell will be attending the first meeting of the Certificate Accreditation Program Advisory Council tomorrow, March 4, 2010, in Washington, DC. The Council is charged with the development of policies and procedures defining the governance and operations model for the ICE accreditation services program, as well as the implementation of a pilot accreditation program. For more information on ICE, please visit www.credentialingexcellence.org.

About eLadder™ Safety
BioSoteria’s eLadder™ Safety is the first and only comprehensive eLearning curriculum in pharmacovigilance. The media-rich courses form a cohesive drug safety training program, with one course building on the other.

eLadder™ Safety is not just a series of PowerPoint presentations repackaged as eLearning curriculum. Each online pharmacovigilance training course is a multimedia experience with practical engaging exercises and knowledge checks, developed by an experienced multi-disciplinary team of subject-matter experts, instructional designers, medical illustrators, graphic designers, animators, eLearning programmers and learning management system (LMS) specialists. The first three courses now available for purchase are:

Course 1: Drug and Device Development and Regulation
Course 2: Clinical Safety Surveillance
Course 3: Postmarketing Pharmacovigilance

To learn more about eLadder™ Safety, view the online demonstration at the BioSoteria website.

About BioSoteria
From strategic risk management consulting and full-service drug safety department capabilities to innovative pharmacovigilance training and education, BioSoteria provides unmatched experience, expertise and leadership to support biopharmaceutical companies’ efforts to maximize the benefit/risk balance. For more information about BioSoteria’s eLadderTM Safety courses or its drug safety services, please visit the company’s website at www.biosoteria.com or call 1 866 660 5553.

###

Read the full story at http://www.prweb.com/releases/pharmacovigilance/training/prweb3678854.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Drug Safety Firm BioSoteria Announces Exponential Growth in 2009
2. BioSoteria CEO to Present at Drug Safety Conference
3. BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification
4. BioSoteria Drug Safety Newsletter Reaches Milestone
5. Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
6. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
7. FMC Agricultural Products Executive Bob Trogele Speaks to the Iowa Agribusiness Showcase & Conference
8. Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board
9. Fibrocell Science, Inc. Names David Pernock Chief Executive Officer
10. Glycos Biotechnologies Appoints Chief Executive Officer
11. Biofuels Technology Leader Qteros Names Industry Veteran John McCarthy President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
BioSoteria eLearning Executive Michelle Flewell Selected for Accreditation Council 
(Date:5/22/2017)... ... 22, 2017 , ... Baltimore biotech firm, PathSensors, announced that ... in developing and issuing recommendations to grow Maryland's biohealth industry and position the ... , The recommendations are contained in a report from the ...
(Date:5/21/2017)... ... 20, 2017 , ... CNSDose is a genetically driven, clinically ... by finding the right antidepressant faster. CNSDose speeds recovery and reduces side ... personalized approach to treatment. , A peer-reviewed and published, 12-week double-blind ...
(Date:5/18/2017)... Malden, Mass. (PRWEB) , ... May 18, 2017 ... ... completed the procedure on April 28, 2017 at the Prince Of Wales Private ... degenerative cervical disc at level C6-C7. The patient failed conservative treatments prior to ...
(Date:5/18/2017)... ... May 17, 2017 , ... NDA Partners Chairman Carl ... CEO of Eurofins Advantar Laboratories and President of Pharmaceutical Development Business Unit of Cardinal ... at Eurofins and Cardinal Health, he was former Chief Operating Officer at Anaborex, Senior ...
Breaking Biology Technology:
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):